lmmunocytology in Malignant Pleural Mesothelioma
|
|
- Buddy Parsons
- 6 years ago
- Views:
Transcription
1 lmmunocytology in Malignant Pleural Mesothelioma Expression of Tumor Markers and Distribution of Lymphocyte Subsets ]osune Guzman, M.D.;* Klaus]. Bross, M.D.;t Gebhard Wurtemberger, M.D.;t. and Ulrich Costabel, M.D., F.C.C.P. We studied the reactivity of malignant mesothelioma cells with tumor marlters and the phenotypes of lymphocyte subsets in pleural effusions from 14 patients with malignant mesothelioma. For identification of cell surface antigens with monoclonflj antibodies, the adhesive slide assay was used. The reaction pfltlem of mesothelioma cells was found to be CEA neative, Leu M1 negative, EMA positive, BMA- 120 positive, My 4 positive, and BA-2 positive. The surface morphology of mesothelioma cells may be of additional help for diagnosis. By these markers, the distinction between mesotheliomas and car~119mas is facilitated. The differentiation of reactive benign mesothelial hyperplasia from malignant mesothelioma by surface marker staining is not yet possible, however. In many effusions in this study, a concomitant T-lymphocytosis was observed with a nonspecific increase in the CD4/CD8 ratio, as known for other pleural diseases. (Che&t 1989; 95:590-95) CEA = carcinoembryonic antigen; EMA =epithelial membrane antigen; MAbs =monoclonal antibodies; PAP= peroxidase-antiperoxidase; NK =natural killer he cytologic diagnosis of malignant mesothelioma T in serous effusions continues to present difficulties of practical importance. The conventional cytology is often limited by the problems encountered in distinguishing malignant mesothelioma from metastatic adenocarcinoma or from reactive benign mesothelial hyperplasia. Since monoclonal antibodies (MAbs) for the identification of antigens on tumor cells have become available, several reports on the reactivity of mesothelioma cells with tumor markers have been published with different results. Most authors agree that mesothelioma cells are negative for carcinoembryonic antigen (CEA), but show a positive reaction for epithelial membrane antigen (EMA). 1 5 We studied the reaction pattern of malignant mesothelioma cells in pleural effusions with monoclonal antibodies against cell surface antigens using a special method for cell-preparation that allows a clear demonstration of the cell surface configuration. This may be of additional help for the recognition of mesothelioma cells, which in most cases contain profuse, longbranching microvilli, as previously described only in electron microscopic studies.~ The second aim of this study was to determine the phenotypes of pleural lymphocyte subsets in malignant pleural effusions due to mesothelioma, because recently interest has in- From the *Pathologisches lnstitut; the t Abteilung Hiimatologie/ Onkologie; the tabteilung Pneumologie, Universitatsklinik Freiburg i.br.; and the Abteilung Pneumologie/AIIergologie, Ruhrlandklinik, Essen-Heidhausen, West Germany. Manuscript received February 24; revision accepted July 25. Reprint requests: Dr. Guzman, lbthologisches lnstitut der Universitat, Albertstr 19, D-7800 Freiburg, ~st Gennany 590 creased in the local distribution of immune effector cells isolated from tumors or malignant effusions. 9 Lymphocyte subsets in pleural effusions from malignant mesothelioma have previously been described only sporadically. to MATERIAL AND METHODS \\e studied 14 patients with pleural effusions due to malignant mesothelioma of the pleural cavity. Our population under study consisted of 12 men and two women: mean age, 65::!: 10 years; range, 50 to 81 years. The tumors had been classified at the pleuropneumonectomy specimen obtained by surgery. They all were PAS negative. The histology of 12 cases classified as epithelial mesothelioma showed numerous mesothelium-lined clefts and more solid "epithelial" nests of cells. Two cases (nos. 13 and 14) showing a sarcomatous and a solid "epithelial" component were classified as biphasic mesothelioma. The pleural effusions for this study were obtained prior to surgical procedure or any other therapy. Exposure to asbestos was known in only six cases. Cells from 10 ml of pleural effusion stored in EDTA-coated tubes were obtained for immunocytochemical studies. For this purpose the adhesive slide assay was used Mononuclear cells were separated by Ficoll-Hypaque centrifugation." To facilitate the identification of macrophages, an incubation with a solution containing latex beads (1 ml minimum essential medium, 50 ~~ol bovine serum albumin [BSA] 22 percent, 5 ILl latex stock solution/sigma No. LB-8) for 8 min at 37"C was performed. For immunocytochemistry the cells were added to each of the reaction areas of adhesive glass slides (Superior, Bad Mergentheim) and fixed with glutaraldehyde (0.05 percent in 0.1 M phosphate-buffered saline solution, ph 7.8) for 5 min to block Fc-receptors and preserve cell morphology. The adhesive glass slides contain 12 cell-adhesive reaction areas separated by a hydrophobic coating of the remaining area of the slide surface. By this principle, 12 immunoreactions can be performed in parallel on the same glass slide with low amounts of antibodies and cells. 13 Jmmunocytology in Malignant Pleural Mesothelioma (Guzman et a/)
2 co CD3 CD4 CD8 CD14 CD20 CD25 CD38 HLA-DR CDIS Name CEA3-13 EMA BMA-120 OKT3 OKT4 OKT8 My4 Bl anti-tac OKTIO Ia BA-2 Leu M 1 Leu7 OKT9 HLA-1 HLE-1 Table 1-Monoclonol Anitbodiu Uaed in thia Study Supplier Immunbiologie, Freiburg (W. Ger.) Dakopatts Behring Or tho Coulter Coulter Becton-Dickinson Coulter Hybritech Becton-Dickinson Becton-Dickinson Hybritech Hybritech Target Carcinoembryonic antigen 1:50 Dilution Epithelial membrane antigen 1:100 Endothelial cells 1:20 T-lymphocytes 1:100 Helper/inducer T cells 1:50 Suppressor/cytotoxic T cells 1:50 Monocytes, macrophages 1:100 Pan-B-lymphocytes 1:100 Interleukin-2-receptor 1:100 Premature T cells, activated T cells 1:50 B-lymphocytes, activated T-lymphocytes, 1:50 monocytes Cells in early stage of lymphoid 1:50 differentiation 1: Granulocytes (monocytes) 1:100 Natural killer cells 1:100 Transferrin-receptor, proliferating cells 1:100 Human leukocyte antigen 1:100 Human leukocyte antigen 1:100 Cluster designation. The immunostaining was performed according the peroxidaseantiperoxidase (PAP) technique with diaminobenzidine (0.06 percent solution) as substrate followed by postfixation with OsO, 2 percent. The monoclonal antibodies used in this study are listed in Table 1. To evaluate the reaction, the slides were viewed by a light microscope with a magnification 400-fold. Positive-reacting cells were clearly recognized by the dark brown color of the cell membrane (positive cell surface reaction). Two hundred tumor cells or lymphocytes were counted in each reaction area, and the positivereacting cells were calculated as percentage of total tumor cells or lymphocytes, respectively. A differential cell count of mononuclear cells to determine the percentage of tumor cells, macrophages, and lymphocytes was also performed on 200 cells in each case after Ficoll-Hypaque centrifugation. The mean values± SD were calculated for all parameters. RESULTS In 12 of 14 cases, the proportions of tumor cells in the effusions ranged from 2 to 71 percent. In two cases, no malignant cells were present, but an elevated percentage of lymphocytes was observed (95 percent and 96 percent, respectively). The reactivity of the mesothelioma cells with the study markers is shown in Table 2. In all cases EMApositive tumor cells were found, with a mean proportion of 47 ± 33 percent positive-reacting tumor cells (Fig 1). BMA-120-positive tumor cells were aiso present in all cases, with a mean proportion of 80 ± 12 percent of tumor cells being positive (Fig 2). CEA 3-13 positivity of tumor cells was never observed. In addition, the reactivity of the tumor cells with the granulocyte marker Leu M1 was consistently negative. Regarding the monocyte/macrophage marker My4, however, some mesothelioma cells interestingly re- Table 2-Clinical Data of the Study Group with Malignant Meaothelioma and Reactivity of Meaothelioma Cella in the Pleural Fluid* Patient No. Age, yr/sex Cell type CEA3-13 EMA BMA-120 My4 LeuM1 HLA-DR BA-2 OKT9 1 69/M Epithelial /M Epithelial /M Epithelial /F Epithelial IM Epithelial ND /M Epithelial NO /F Epithelial NO /M Epithelial /M Epithelial /M Epithelial /M Epithelial ND /M Epithelial NO /M Biphasic No mesothelioma cells present in the pleural fluid 14 46/M Biphasic No mesothelioma cells present in the pleural fluid Mean±SD 0 47±33 80±12 14± ±17 67±26 30±22 *Monoclonal antibody-positive mesothelioma cells are expressed as percentage of total mesothelioma cells. NO, not determined. CHEST I 95 I 3 I MARCH,
3 which is higher than the normal value of 1.8±0.7 for the peripheral blood ratio in our laboratory. 12 The analysis of activation markers on T cells with the monoclonal antibodies CD 25, CD 38, and anti-hla- DR showed that in all cases, only a few T cells from the pleural fluid expressed these markers (Table 3). The monoclonal antibody Leu 7 directed against natural killer (NK) cells was studied in only five cases and reacted positive with 7 ± 6 percent oflymphocytes (range, one to 16). DISCUSSION This study investigated the reactivity of mesothelioma cells with a panel of MAbs against cell membrane antigens. Our preparation technique making use of the adhesive glass slide assay offers several advantages. It permits the preservation of excellent cell morphology and of the integrity of the cell membrane structure. The cells do not lose their three-dimensional shape during the fixation and staining procedure. The intact structure of the cell membrane allows isolated membrane staining of the cell surface. Because the antibodies cannot penetrate into the cytoplasma, in- FlGVRE 1A( upper). lmmunostaining of mesothelioma cells from the pleural fluid with EMA. The cell surface is partially or completely positive with a hairy reaction pattern (large arrows). Some tumor cells (small arrows), macrophages (m), and lymphocytes (I) are negative. lmmunoperoxidase adhesive slide assay (original magnification x400). FIGVRE 1B (lower). Two groups of mesothelioma cells at higher magnification. Partially positive staining of cell surface with EMA. One tumor cell additionally shows typical roundish intracytoplasmic organella (original magnification x 1,000). acted positive in 11 of 12 cases (mean value 14 ± 15 percent of tumor cells) (Fig 3). A certain percentage of mesothelioma cells also reacted with HLA-DR (mean value 25 ± 17 percent of tumor cells) and with BA-2 (mean value 67 ± 26 percent of tumor cells) in each of the cases studied with these markers. In all cases OKT9 positivity was observed on 30 ± 22 percent of tumor cells. This marker may serve as an index of transferrin-receptor expression, which is connected to cell growth and proliferation. No reactivity of mesothelioma cells with the MAb HLE-1 was found. In all cases mesothelioma cells were HLA-1 positive. The analysis of pleural lymphocyte subpopulations (Table 3) revealed that in all cases the majority of the lymphocytes present were CD3-positive T cells (83 ± 5 percent). The phenotypical characterization of the T-lymphocyte subpopulations demonstrated that 67 ± 9 percent of total lymphocytes were CD4-positive helper/inducer and 20 ± 6 percent were CD8-positive suppressor/cytotoxic T cells. The ratio of helper/inducer to suppressor/cytotoxic T cells was 3. 7 ± 1.4, FlGt:RE 2A (upper). lmmunostaining of mesothelioma cells from pleural fluid with the MAb BMA-120. lmmunoperoxidase adhesive slide assay (original magnification x 400). FlGVRE 2B (lower). Negative control reaction without the first antibody. Mesothelioma cells (arrow), macrophages (m), lymphocytes (l), erythrocytes (e), and one granulocyte (g). No positive-reacting cells present (original magnification X 400). 592 Jmmunocytology in Malignant Pleural Mesothelioma (Guzman at at)
4 F1Gl'RE 3A (upper). lmmunostaining of cells from the pleural fluid with the monocyte/macrophage marker My4. Positive reacting tumor cells I large arrotes ). negative tumor cells I small arrou:s). positive-reacting macrophages (m). negative lymphocytes (l). lm munoperoxidase adhesive slide assay (original magnification X 400). F1Gl'RE 3B llou erj. ~ly4 positive mesothelioma cells at higher magnification. :\ote microvilli on cell surface of two intensively positive tumor cells. Another mesothelioma cell is only weakly and partially positive. ~lacrophages are also positive (m) (original magnification x!,000). tracytoplasmic staining is not observed. This permits the recognition of the typical surface configuration of mesothelioma cells with their long and profuse microvilli in our immunocytochemical preparations, as previously achieved only by electron microscopy. 6 ~ This surface configuration is important for the distinction of mesothelioma cells from adenocarcinoma cells. Regarding the reactivity of mesothelioma cells with MAbs, we never observed an immunostaining with CEA. This is in agreement with most reports from the literature but is in contrast to the weak CEA positivity observed in early studies, 1 s- 18 which were mostly performed on tissue sections and with unabsorbed or polyclonal antibodies to CEA. Thus, nonspecific CEA staining may have occurred in the latter studies. By our opinion, mesothelioma can be excluded when CEA-positive tumor cells are present. The EMA has received a great attention in the literature.u 9 We found strong positivity of mesothelioma cells in all our cases. This is consistent with the results of Cibas et ali but contrary to those of Mason and Bed ross ian. 15 Carcinoma cells (Table 4) and a few activated mesothelioma cells also reacted with this MAb. Our study also demonstrated a strongly positive reaction of mesothelial cells with BMA-120, previously not described for cells from pleural effusions. This finding is not specific, however, for cells of malignant mesothelial origin, because ovarian carcinoma cells in ascites and normal mesothelial cells have also been found to react positive for BMA-120, as detected in our ongoing studies on tumor markers in effusions 21 > (Table 4). As in prior reports, in our study mesothelioma cells did not react with Leu M Since all carcinomas studied in our laboratory did react with Leu M 1 (Table Table 3-Percentage of Tumor Cells, Macrophages, and Immune Effector Cells in the Pleural Fluid of Malignant Mesothelioma* Patient :\o. Tumor Cells ~lacrophages Lymphocytes CD3 CD4 CDS CD4/CD8 CD20 CD25 CD38 HLA-DRt ND ND ND ND ' ND Mean±SD 19±21 34±22 48±30 83±5 67±9 20±6 3.73± ±4 5±2 4±2 16±4 *Differential cell counts are expressed as percentage of total mononucleated cells. Monoclonal antibody positive lymphocytes are expressed as percentage of total lymphocytes. ND, not determined. tonly percentage of positive reacting lymphocytes are shown. CHEST I 95 I 3 I MARCH,
5 Table 4-Comparison of the Immunoreactivity of Malignant Mesothelioma, Carcinomas, and Lymphomas in Pleural Effusions and Ascitic Fluid Studied in our Laboratory* Breast Adenocarcinoma, Small Cell Carcinoma Adenocarcinoma, Mesothelioma Cancer Lung Lung Ovaryt Lymphoma (n= 12) (n=30) (n= 10) (n= 13) (n = 17) (n=9) CEA3-13 0/12 21/30 10/10 6/13 5/ EMA 12/12 30/30 10/10 11/13 17/ BMA /12 10(?)/30~ 3(?)/10~ 1(?)/13~ My4 ll/12 0/30 0/10 0/13 0/ Leu M1 0/12 30/30 10/10 ll/11 17/ HLA-DR 12/12 30/30 10/10 ll/11 17/ BA-2 7n 30/ / OKT9 12/12 20/30 8/10 8/13 12/ HLA-1 12/12 14/30 7/10 4/ HLE-1 0/12 0/30 0/10 0/ /9 *The results are sho\\n as number of positive-reacting cases in each group. t Ascitic fluid. ~Weak reaction. Hodgkin cells positive for leu Ml. 4, Fig 4), this MAb may also be of value for the of total cells after Ficoll-Hypaque centrifugation. distinction between mesothelioma and carcinoma. Regarding the distribution of lymphocyte subsets as Activated mesothelial cells are also negative for Leu studied by their reactivity with a panel of MAbs, there Ml. was a distinct increase in the CD4/CD8 ratio, to a In 11 of 12 cases in this study, the mesothelioma mean value of3. 7 ± 1.4, in comparison with the normal cells reacted positive with the marker My 4, whereas value for the peripheral blood of 1.8 ± 0. 7 in our carcinoma cells studied in our laboratory so far never Iaboratory. 14 Elevated CD4/CD8 ratios in pleural effusions are not limited to patients with mesothelioma, reacted with this marker (Table 4). The My 4 and BA- 2 positivity of mesothelioma cells we observed in our however; they have also been observed in other pleural study has not been previously described to our knowledge. Few activated mesothelial cells were also posiing radiotherapy for malignancies, and effusions owing diseases such as tuberculous pleurisy, pleurisy followtive for these MAbs. to congestive heart failure.z.s Contrary to some carcinomas (Table 4), mesothelioma cells do not lose the reactivity with the MAb was found to be CEA negative, Leu M1 negative, The reaction pattern of mesothelioma in this study HLA-1. On the other hand, HLE-1 may be a useful EMA positive, BMA-120 positive, My 4 positive, BAmarker for the identification of lymphomas, since 2 positive, HLA-1 positive, HLE-1 negative, OKT-9 carcinomas and malignant mesothelioma were always positive, Ia positive. Useful markers for the distinction HLE-1 negative, contrary to lymphomas, which were between mesothelioma and carcinomas are CEA, Leu always positive, except for one case with plasmacytoma. staining for CEA, the surface morphology of mesothe- M1, My 4, and BMA-120. In cases with negative This study revealed that most mesotheliomas are lioma cells may allow the differential diagnosis (Fig characterized by a striking concomitant lymphocytosis 1B and 4). The problem is that at present no MAbs in pleural effusions, reaching values of up to 96 percent can conclusively distinguish reactive benign mesothelial hyperplasia from malignant mesothelioma. This differentiation still depends on morphologic criteria of cell number, size, and clustering. Specific markers reacting exclusively with malignant mesothelioma cells and not with reactive mesothelial cells will therefore be required in the future to facilitate the cytologic diagnosis of malignant mesothelioma. FIGt:RE 4. Immunostaining of tumor cells from adenocarcinoma of the lung in the pleural fluid with the granulocyte marker Leu MI. One tumor cell (arrow) and one granulocyte (g) are positive. The macrophages ( ma) are negative. One erythrocyte (e). Original magnification X 1,000. REFERENCES 1 Cibas ES, Corson JM, Pinkus GS. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions. Hum Pathol 1987; 18: Ghosh AK, Gatter KC, Dunnill MS, Mason DY. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies. J Clin Pathol 1987; 40: Wang NS, Huang SN, Gold P. Absence of carcinoembryonic 594 lmmunocytology in Malignant Pleural Mesothelioma (Guzman eta/)
6 antigen-like material in mesothelioma. Cancer 1979; 44: Whitaker D, Sterrett GF, Shilkin KB. Detection of tissue CEA- Iike substance as an aid in the differential diagnosis of malignant mesothelioma. Pathology 1982; 14: Kwee WS, Veldhuizen Rw, Golding RP, Mullink H, Starn J, Donner R, et al. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Virchows Arch Pathol Anat 1982; 397: Wang NS. Electron microscopy in the diagnosis of pleural mesotheliomas. Cancer 1973; 31: Suzuki Y, Churg J, Kannerstein M. Ultrastructure of human malignant diffuse mesothelioma. Am J Pathol1976; 85: Warhol MJ, Hickey WF, Corson JM. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Am J Surg Pathol1982; 6: Haskill S, Koren H, BeckerS, Fowler W, Walton L. Mononuclearcell infiltration in ovarian cancer: II. Immune function of tumor and ascites-derived inflammatory cells. Br J Cancer 1982; 45: Ghosh AK, Spriggs AI, Mason DY. Immunocytochemical staining of T and B lymphocytes in serous effusions. J Clin Pathol 1985; 8: Bross KJ, Pangalis GA, Staatz C. Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation 1978; 25: Costabel U, Bross KJ, Matthys H. The immunoperoxidase slide assay: a new method for the demonstration of surface antigens on bronchoalveolar lavage cells. Bull Eur Physiopathol Respir 1985; 21: Guzman J, Costabel U, Bross KJ, Wiehle U, Schaefer HE. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer. Acta Cytol 1988; 32: Nagasawa T, Nagasawa S. Enrichment of malignant cells from pleural effusions of patients with malignant and non-malignant diseases. Cancer Lett 1984; 22: Mason MR, Bedrossian CWM. Value of immunocytochemistry in the study of malignant effusions. Diagn Cytopathol 1985; 1: Corsun JM, Pinkus GS. Mesothelioma: profile ofkeratin proteins and carcinoembryonic antigen. Am J Pathol1982; 108: Said JW, Nash G, Tepper G, Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma. Hum Pathol 1983; 14: Holden J, Churg A. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol1984; 8: Walts AE, Said JW, Said MB, Shintaku IP. Epithelial membrane antigen in the cytodiagnosis of effusions and aspirates: immunocytochemical and structural localization in benign and malignant cells. Diagn Cytopathol1987; 3: Guzman J, Hilgarth M, Bross KJ, Ross A, Wiehle U, Kresin V. et al. Malignant ascites of serous papillary ovarian adenocarcinoma: an immunocytochemistry study of tumor cells. Acta Cytol 1988; 32: Pinkus GS, Thomas P, Said JW. Leu-M1-A marker for Reed- Sternberg cells in Hodgkins disease: an immunoperoxidase study of paraffin-embedded tissues. Am J Pathol1985; 119: Sheibani K, Battifora H, Burke JS, Rappaport H. Leu-M1 antigen in human neoplasms: an immunohistologic study of 400 cases. Am J Surg Pathol1986; 10: Otis ChN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma: a hi-institutional study of 47 cases. Am J Surg Pathol 1987; 11: Battifora H, Kopinski MI. Distinction of mesothelioma from adenocarcinoma. Cancer 1985; 55: Guzman J, Bross KJ, Wiirtemberger G, Freudenberg N, Costabel U. Tuberculous pleural effusions: lymphocyte phenotypes in comparison with other lymphocyte-rich effusions. Diagn Cytopath (in press) CHEST I 95 I 3 I MARCH,
Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationImmunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies
J Clin Pathol 1987;40:19-25 Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies ANNA K GHOSH, K C GATTER, M S DUNNILL, D Y MASON
More informationACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION
POL J PATHOL 2011; 2: 95-100 ACCURACY OF IMMUNOHISTOCHEMISTRY IN EVALUATION OF MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS FERESHTEH ENSANI, FARNAZ NEMATIZADEH, GITI IRVANLOU Department of Cytology, Cancer
More informationWT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids
Anatomic Pathology / WT1, ESTROGEN RECEPTOR, AND PROGESTERONE RECEPTOR IN CYTOLOGY OF BODY FLUIDS WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic
More informationAscitic Fluid and Use of Immunocytochemistry. Mercè Jordà, University of Miami
Ascitic Fluid and Use of Immunocytochemistry Mercè Jordà, University of Miami Is It Malignant? Yes? No Ascitic Fluid Cytomorphologic Useful Findings Tight clusters with smooth borders Cellular and nuclear
More informationImmunohistochemistry on Fluid Specimens: Technical Considerations
Immunohistochemistry on Fluid Specimens: Technical Considerations Blake Gilks Dept of Pathology University of British Columbia, Vancouver, BC, Canada Disclosures None Learning Objectives At the end of
More informationCOMPARATIVE STUDY OF CELL - BLOCKS & ROUTINE CYTOLOGICAL SMEARS OF PLEURAL & PERITONEAL FLUIDS IN SUSPECTED CASES OF MALIGNANCY
ORIGINAL RESEARCH COMPARATIVE STUDY OF CELL - BLOCKS & ROUTINE CYTOLOGICAL SMEARS OF PLEURAL & PERITONEAL FLUIDS IN SUSPECTED CASES OF MALIGNANCY Geethu G Nair,*, Anupama Achyuthan Manjula 2 Assistant
More informationApplications of Flow Cytometry in Diagnostic Cytology of Body Cavity Fluids
Applications of Flow Cytometry in Diagnostic Cytology of Body Cavity Fluids Awtar Krishan, PhD. Professor, Department of Pathology University of Miami School of Medicine akrishan@med.miami.edu Beckman
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationreact with these antibodies. Reports from different recent review Crocker and Burnett suggested that
JClin Pathol 1989;42:1096-1 100 Laboratory techniques Comparative quality assessment in immunocytochemistry: pilot study of CD15 staining in paraffin wax embedded tissue in Hodgkin's disease CAROLE A ANGEL,
More informationComparison of tumour markers in malignant
Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma AR GIBBS, R HARACH, JC WAGNER, B JASANI Thorax 1985;40:91-95 From the Pathology Department, Welsh National School, Cardiff,
More informationKeratins of Different Molecular Weight in Exfoliated Mesothelial and Adenocarcinoma Cells An Aid to Cell Identification
Keratins of Different Molecular Weight in Exfoliated Mesothelial and Adenocarcinoma Cells An Aid to Cell Identification ANN E. WALTS, M.D., JONATHAN W. SAID, M.B., CH.B., I. PETER SHINTAKU, PH.D., AARON
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationImmunohistochemical Evaluation of Necrotic Malignant Melanomas
Anatomic Pathology / EVALUATION OF NECROTIC MALIGNANT MELANOMAS Immunohistochemical Evaluation of Necrotic Malignant Melanomas Daisuke Nonaka, MD, Jordan Laser, MD, Rachel Tucker, HTL(ASCP), and Jonathan
More informationWell-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report
Showa Univ J Med Sci 25 1, 67 72, March 2013 Case Report Well-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report Yuri TOMITA
More informationCytological evaluation of effusion fluid with cell block technique and cytology smears among Sudanese patients
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 3/ June 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Cytological evaluation of effusion fluid with cell block technique
More informationFollow up of the Guidelines for Cytopathologic Diagnosis of Malignant Mesothelioma
Follow up of the Guidelines for Cytopathologic Diagnosis of Malignant Mesothelioma Assoc. Prof. Katalin Dobra, Senior Lecturer in Molecular Pathology Karolinska University Hospital Stockholm, Sweden Disclosure
More informationMesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016
Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar
More informationPreparation of bronchoalveolar lavage fluid with microscope slide smears
Eur Respir J, 1996, 9, 63 68 DOI: 1.1183/931936.96.9363 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 93-1936 TECHNICAL NOTE Preparation of bronchoalveolar
More information, , 2011 HODGKIN LYMPHOMA
European Federation of Cytology Societies 4tu Annual Tutorial in Cytopathology Trieste, June 6-10, 2011 HODGKIN LYMPHOMA Classification The World Health Organization Classification of Lymphomas (2001)
More informationCD15 and CEA expression in thymic epithelial neoplasms
Turkish Journal of Cancer Volume 8, No., 8 CD and CEA expression in thymic epithelial neoplasms AYTEKİN AKYOL, AYŞEGÜL ÜNER Hacettepe University, Department of Pathology, Ankara-Turkey ABSTRACT The aim
More informationMorphologic and Immunocytochemical Performances of Effusion Cell Blocks Prepared Using 3 Different Methods
Anatomic Pathology / Performance of Different Cell Block Preparation Techniques Morphologic and Immunocytochemical Performances of Effusion Cell Blocks Prepared Using 3 Different Methods Xin Jing, MD,
More informationDifferentiation of Tumors with Specific Red Cell Adherence (SRCA) test
753 Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test Dr. Abhishek A Mangaonkar *, Dr. A G Valand 1 Intern, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai, India 2 Professor,
More informationACCME/Disclosures. Case 4 USCAP Pulmonary Panel Case 4 History
Case 4 USCAP Pulmonary Panel 2016 Andrew Churg, MD Department of Pathology Vancouver General Hospital & University of British Columbia Vancouver, BC achurg@mail.ubc.ca. ACCME/Disclosures The USCAP requires
More informationSerous Effusions. Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland
Serous Effusions Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland Serous membrane Body cavities: Pleural Pericardial Peritoneal Effusion = Excess of fluid 80% Benign 20% Malignant
More informationRespiratory Interactive Session. Elaine Borg
Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal
More informationExpression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Peiguo G. Chu, M.D., Ph.D., Lawrence M. Weiss, M.D. Department of Pathology, City of Hope National Medical Center,
More informationT he diagnosis of malignant mesothelioma is dependent on
662 ORIGINAL ARTICLE Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies A S Abutaily, B J Addis, W R Roche... See
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Utility of Modified Cell Block Technique in Cases of Pleural Effusion Suspected of Malignancy
More informationTitle Receptor, and Laminin/Collagen Rece. Citation Acta medica Nagasakiensia. 1993, 38
NAOSITE: Nagasaki University's Ac Title Author(s) Immunohistochemical Investigation o Keratin, EMA, Laminin, Fibronectin, Receptor, and Laminin/Collagen Rece Senba, Masachika; Zhong, Xue-Yun; I Citation
More informationComparison of Keratin Monoclonal Antibodies MAK-6, AE1AE3, and CAM-5.2
Comparison of Keratin Monoclonal Antibodies MAK6, AEAE, and CAM5. MARGARET B. LISTROM, M.D. AND LESLIE W. DALTON, M.D. Two routinely used antikeratin monoclonal antibodies, AELAE (Hybritech Inc., La Jolla,
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More informationUltrastructural Study of Human Natural Killer CNK) Cell*)
Hiroshima Journal of Medical Sciences Vol. 31, No. 1, March, 1982 HJIM 31-6 31 Ultrastructural Study of Human Natural Killer CNK) Cell*) Yoshinori KAWAGUCHI, Eishi KITTAKA, Yoshito TANAKA, Takeo TANAKA
More informationNotice of Faculty Disclosure
The Separation of Benign and Malignant Mesothelial Proliferations: Lessons from Morphology and Molecular Biology Andrew Churg, MD Departments of Pathology University of British Columbia & Vancouver General
More informationImmunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors.
ISPUB.COM The Internet Journal of Pathology Volume 13 Number 2 Immunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors. A Baghla, S Choudhry, A Kataria Citation A Baghla, S Choudhry,
More informationKey Words: PAX8; PAX2; Müllerian; carcinoma; effusion
Diagnostic Utility of PAX8 and PAX2 Immunohistochemistry in the Identification of Metastatic Müllerian Carcinoma in Effusions William Wiseman, D.O., Claire W. Michael, M.D., and Michael H. Roh, M.D., Ph.D.*
More informationMalignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry
766 J Clin Pathol 2001;54:766 770 Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry Department of Pathology, Victoria Infirmary, Langside
More informationOriginal Article Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
Pathology International 2007; 57: 190 199 doi:10.1111/j.1440-1827.2007.02080.x Original Article Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
More informationmesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material OV 632 and MOC 31 in the diagnosis of
6266 Clin Pathol 1995;48:626-630 Department of Histopathology, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS C Edwards J Oates Correspondence to: Dr C Edwards. Accepted for publication
More informationCitation Acta Medica Nagasakiensia. 1992, 37
NAOSITE: Nagasaki University's Ac Title Author(s) A Study on the Expression of EGFR a Content in the Stomach Cancer Tissu Nakazaki Takayuki Citation Acta Medica Nagasakiensia. 1992 37 Issue Date 1992-12-25
More informationImmunoperoxidase Localization of Keratin in Human
Immunoperoxidase Localization of Keratin in Human Neoplasms A Preliminary Survey Richard Schlegel, MD, PhD, Susan Banks-Schlegel, PhD, Janet A. McLeod, BA, and Geraldine S. Pinkus, MD The distribution
More informationLách
Lách Lách Lách Lách Splenogonadal fusion. Splenic tissue is attached to testicular tissue. Pseudocyst (false or secondary cyst). A, Outer aspect. Pseudocyst (false or secondary cyst). B, Inner surface.
More informationIntroduction. 23 rd Annual Seminar in Pathology. FLUIDS, Part 1. Pittsburgh, PA Gladwyn Leiman UVMMC, VT
23 rd Annual Seminar in Pathology Pittsburgh, PA Gladwyn Leiman UVMMC, VT FLUIDS, Part 1 "Blue walls", Claudia Hansen, 2009 Introduction o Challenging to everyone o Almost any benign or malignant process
More informationbenign and malignant gynaecological conditions were
J Clin Pathol 1986;39:1335-1339 Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy ANNA K GHOSH,* AI SPRIGGS,t M CHARNOCKt From the *Nuffield
More informationIMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS
LECTURE: 07 Title: IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS LEARNING OBJECTIVES: The student should be able to: The chemical nature of the cellular surface receptors. Define the location of the
More informationKey Words: effusion; carcinoma; immunocytochemistry; direct smear; cytology
The Application of Immunocytochemistry to Direct Smears in the Diagnosis of Effusions Stewart M. Knoepp, M.D., Ph.D., { Jeremiah Placido, M.D., { Kristina L. Fields, B.S., Dafydd Thomas, M.D., Ph.D., and
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationDuring recent decades, many studies have investigated
Differential Diagnosis of Benign and Malignant Mesothelial Proliferations on Pleural Biopsies Philip T. Cagle, MD; Andrew Churg, MD, PhD Context. Although much of the pathology literature focuses on differential
More informationEditorial Process: Submission:11/02/2017 Acceptance:05/19/2018
RESEARCH ARTICLE Editorial Process: Submission:11/02/2017 Acceptance:05/19/2018 Comparative Analysis of Modified Liquid-Based Cytology and CytoRich Red Preparation in Assessment of Serous Effusion for
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationSuccessful flow cytometric immunophenotyping of body fluid specimens
Successful flow cytometric immunophenotyping of body fluid specimens Fiona E. Craig, MD Division of Hematopathology Mayo Clinic Arizona 2017 MFMER slide-1 Financial disclosure No conflicts 2017 MFMER slide-2
More informationImmunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies
J Clin Pathol 1983;36:1154-1164 Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies AK GHOSH,* Al SPRIGGS,t J TAYLOR-PAPADIMITRIOU,t DY MASON*
More informationINTRODUCTION TO PATHOLOGICAL TECHNIQUES. 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH)
INTRODUCTION TO PATHOLOGICAL TECHNIQUES 1. Types of routine biopsy procedures 2. Special exams (IHC, FISH) Biopsy-Indications Diffuse/multifocal lesions (neoplastic, inflammatory, etc) Etiology of the
More informationCase 1. Slide 1 History: 65 year old male presents with bilateral pleural effusions, a 40 pack year smoking history and peripheral and hilar lung
Case 1. Slide 1 History: 65 year old male presents with bilateral pleural effusions, a 40 pack year smoking history and peripheral and hilar lung masses. Specimen shown is from a tap of the pleural effusion.
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More informationExfoliative cytology of diffuse mesothelioma
Exfoliative cytology of diffuse mesothelioma G. HEFIN ROBERTS AND G. M. CAMPBELL From the Pathology Department, Southern General Hospital, Glasgow J. clin. Path., 1972, 25, 577-582 SYNOPSIS The exfoliative
More informationp53 expression in invasive pancreatic adenocarcinoma and precursor lesions
Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More informationLung Cytology: Lessons Learned from Errors in Practice
Lung Cytology: Lessons Learned from Errors in Practice Stephen S. Raab, M.D. Department of Laboratory Medicine Eastern Health and Memorial University of Newfoundland, St. John s, NL and University of Washington,
More informationImmunocytochemical staining of T and B lymphocytes in serous effusions
J Clin Pathol 1985;38:608-612 mmunocytochemical staining of T and B lymphocytes in serous effusions AK GHOH, Al PRGG,* DY MAON From the Nuffield Department ofpathology, John Radcliffe Hospital, Oxford,
More informationGATA3: A Promising Marker for Metastatic Breast Carcinoma in Serous Effusion Specimens
GATA3: A Promising Marker for Metastatic Breast Carcinoma in Serous Effusion Specimens Paul W. Shield, PhD, FFSc(RCPA) 1,2 ; David J. Papadimos, MBBS, FRCPA 1,3 ; and Michael D. Walsh, PhD 3 BACKGROUND:
More informationNovocastra Liquid Mouse Monoclonal Antibody Myeloperoxidase
Novocastra Liquid Mouse Monoclonal Antibody Myeloperoxidase Product Code: NCL-L-MYELO Leica Biosystems Newcastle Ltd Balliol Business Park West Benton Lane Newcastle Upon Tyne NE12 8EW United Kingdom (
More informationImmunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracy in equivocal smears
59 Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracy in equivocal smears Helma Motherby a,, Nicolaus Friedrichs a, Mary Kube a, Bahram Nadjari a, Kristiane
More informationINDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques,
INDEX Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, minimally invasive. See Minimally invasive adenocarcinoma (MIA). Airway-centered interstitial fibrosis, 183 184 ALK (anaplastic
More informationLectin binding properties of cells from serous effusion and peritoneal washing specimens
J Clin Pathol 1989;42:1178-1 183 Lectin binding properties of cells from serous effusion and peritoneal washing specimens P W SHIELD From the Queensland Cytology Service, Department of Pathology, Royal
More informationCharacterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67
J Clin Pathol 1992;45:201-205 201 Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67 Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital
More informationFine-Needle Aspiration Cytology in the Diagnosis of Lymphoma The Next Step
Fine-Needle Aspiration Cytology in the Diagnosis of Lymphoma The Next Step Linda M. Sandhaus, MD Since 985, almost 2 articles have been published in the medical literature on the subject of fine-needle
More informationStromal Fat Content of the Parathyroid Gland
Stromal Fat Content of the Parathyroid Gland TAKAO OBARA,* YOSHIHIDE FUJIMOTO* AND MOTOHIKO AIBA** *Department of Endocrine Surgery and **Department of Surgical Pathology, Tokyo Women's Medical College,
More informationCYTOMORPHOLOGY MODULE 28.1 INTRODUCTION OBJECTIVES 28.2 GENERAL GUIDELINES. Notes
28 CYTOMORPHOLOGY 28.1 INTRODUCTION Light microscopic examination of stained cells in smears is the method of choice of diagnostic cytology. It allows classification of most normal cells as to type and
More informationClinicopathological Study on Malignant Pleural Mesotheliomas
Table of Contents Clinicopathological Study on Malignant Pleural Mesotheliomas PL-4-03 Kenzo Hiroshima Kenzo Hiroshima 1, Akira Iyota 1, Kiyoshi Sibuya 1, Toshikazu Yusa 2, Takehiko Fujisawa 1 and Yukio
More informationFINALIZED SEER SINQ S MAY 2012
FINALIZED SEER SINQ S MAY 2012 : 20120039 Primary site/heme & Lymphoid Neoplasms: What site do I code this to and what rule applies? How did you arrive at this? Please advise. See discussion. Patient with
More informationantibodies in the diagnosis of Hodgkin' s disease
J Clin Pathol 1985;38:1241-1246 Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin' s disease AJ NORTON, PG ISAACSON From the Department ofhistopathology, Medical School,
More informationRCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer
JBUON 2019; 24(2): 715-719 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE RCD24, B7-H4 and PCNA expression and clinical significance in ovarian
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationInvasion to the visceral pleura is an important component
Diagnosis of Visceral Pleural Invasion by Lung Cancer Using Intraoperative Touch Cytology Yushi Saito, MD, PhD, Yosuke Yamakawa, MD, PhD, Masanobu Kiriyama, MD, PhD, Ichiro Fukai, MD, PhD, Satoshi Kondo,
More informationMonocyte subsets in health and disease. Marion Frankenberger
Monocyte subsets in health and disease Marion Frankenberger main cellular components: Leukocytes Erythrocytes Composition of whole blood Monocytes belong to the cellular components of peripheral blood
More informationThe role of Electron Microscopy in the study of cytologic specimens. Elba A. Turbat-Herrera, MD
The role of Electron Microscopy in the study of cytologic specimens. Elba A. Turbat-Herrera, MD Louisiana State University Health Sciences Center Shreveport, LA, USA Introduction The field of Cytology
More informationBIOTARGET-1 SERUM-FREE MEDIUM
TECHNICAL INFORMATION BIOTARGET-1 SERUM-FREE MEDIUM Cat. No. 05-080-1 Introduction The BIOTARGET-1 formulation has been developed specifically for use with mononuclear cells (lymphocytes and monocytes)
More informationA Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases
Anatomic Pathology / Peritoneal Mesothelioma A Useful Antibody Panel for Differential Diagnosis Between Peritoneal Mesothelioma and Ovarian Serous Carcinoma in Japanese Cases Yukio Takeshima, MD, Vishwa
More informationTitleSarcomatoid carcinoma of the bladde.
TitleSarcomatoid carcinoma of the bladde Author(s) Takashi, Munehisa; Sakata, Takao; N Tatsuya; Miyake, Koji Citation 泌尿器科紀要 (1992), 38(1): 67-70 Issue Date 1992-01 URL http://hdl.handle.net/2433/117446
More informationDifferential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material
508 Al-Muhannadi N, et al., 2011; 10 (4): 508-515 ORIGINAL ARTICLE October-December, Vol. 10 No.4, 2011: 508-515 Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical
More informationHepatocyte Nuclear Factor-1b Is Not a Specific Marker of Clear Cell Carcinoma in Serous Effusions
Hepatocyte Nuclear Factor-1b Is Not a Specific Marker of Clear Cell Carcinoma in Serous Effusions Ben Davidson, MD, PhD 1,2 BACKGROUND: The transcription factor hepatocyte nuclear factor-1b (HNF1b) has
More informationCluster designation 5 staining of normal and non-lymphoid neoplastic skin*
J Cutan Pathol 2005: 32: 50 54 Copyright # Blackwell Munksgaard 2005 Blackwell Munksgaard. Printed in Denmark Journal of Cutaneous Pathology Cluster designation 5 staining of normal and non-lymphoid neoplastic
More informationValue of CD 1 5 immunostaining in diagnosing Hodgkin's disease: a review of published literature
J Clin Pathol 1987;40:1298-1304 Value of CD 1 5 immunostaining in diagnosing Hodgkin's disease: a review of published literature P A HALL,*t A J D'ARDENNE* From the Department of *Histopathology and tlmperial
More informationImmunocytochemical detection of XIAP in body cavity effusions and washes
& 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Immunocytochemical detection of XIAP in body cavity effusions and washes Maoxin Wu, Songyang Yuan, Arnold H Szporn, Li
More informationCOURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16
COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand
More informationSupplemental materials
Supplemental materials 1 Supplemental Fig. 1 Immunogram This immunogram summarizes patient clinical data and immune parameters at corresponding time points for Patient IMF-32. The top panel illustrates
More informationFlow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma
Flow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma Maryalice Stetler-Stevenson, M.D., Ph.D. Flow Cytometry Unit, Laboratory of Pathology, DCS, NCI, NIH DEPARTMENT OF
More informationSenior of Histopathology Department at Khartoum, Radiation and Isotopes Center
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 2/ May 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Immune Histochemical Evaluation of AMACR (P504S) in Prostatic Adenocarcinoma
More informationImmunohistochemical Analysis of Progressively Transformed Follicular Centers
Analysis of Progressively Transformed Follicular Centers JOOST J. VAN DEN OORD, M.D., CHRIS DE WOLF-PEETERS, M.D., AND VALEER J. DESMET, M.D. Using an in situ immunohistochemical technic and a panel of
More informationPeripheral blood Pleural effusion in a cat
Tools for the Diagnosis of Lymphoproliferative Diseases When is it difficult to diagnose lymphoproliferative disease? Persistent lymphocytosis consisting of small Lymph node aspirates containing an excess
More informationApplications of IHC. Determination of the primary site in metastatic tumors of unknown origin
Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationBiopsy Interpretation of Spindle cell proliferations of the Serosa
Biopsy Interpretation of Spindle cell proliferations of the Serosa Richard Attanoos, Cardiff. U.K. Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee)
More informationCitation 京都大学結核胸部疾患研究所紀要 (1986), 19(1/2): 23.
TitleImmunohistochemical Studies on Smal Author(s) SHAW, JinBao; ITO, Motohiko Citation 京都大学結核胸部疾患研究所紀要 (1986), 19(1/2): 23 Issue Date 1986-08-31 URL http://hdl.handle.net/2433/52127 Right Type Departmental
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationEpithelial mesotheliomas can be extremely difficult to distinguish
ORIGINAL ARTICLE The Use of Pleural Fluid scd44v6/std Ratio for Distinguishing Mesothelioma from Other Pleural Malignancies José M. Porcel, MD,* Aureli Esquerda, PharmD, Francisco Rodriguez-Panadero, MD,
More informationNovel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates
Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Christopher Turner, MD Vice President, Clinical Science 04 November 2016 Uveal Melanoma Celldex Pipeline CANDIDATE INDICATION Preclinical
More information